Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Bota, DA; Eroglu, Z; Reardon, DA; Fu, BD; Norfleet, J; Desjardins, A; Linskey, ME; Peters, K; Friedman, HS; Vredenburgh, JJ

Published Date

  • May 20, 2011

Published In

Volume / Issue

  • 29 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X


  • English